Evidence map›Paper›PMID 24609929›Full record

GuidelineEuropean journal of nuclear medicine and molecular imaging2014

The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers.

Francesco Giammarile, M Fani Bozkurt, David Cibula, Jaume Pahisa, Wim J Oyen, Pilar Paredes, Renato Valdes Olmos, Sergi Vidal Sicart

Registry-linked trialAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in European journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02494063 (A Prospective Observational Trial on Sentinel Lymph Node Biopsy in Patients With Early Stage Cervical Cancer), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02494063 completednot on this mapstarted 2016, after this paper: background citation

A Prospective Observational Trial on Sentinel Lymph Node Biopsy in Patients With Early Stage Cervical Cancer

Typeobservational_patient_registrySponsorCharles University, Czech RepublicRan2016 to 2024Enrolled600ConditionsCervical CancerArmsSentinel lymph node biopsy, At least unilateral systematic pelvic lymph node dissection
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Article
  3. The role of technetium-99m isotope in sentinel lymph node identification in gynecological cancers.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  4. Review
  5. Molecular image-guided surgery in gynaecological cancer: where do we stand?European journal of nuclear medicine and molecular imaging · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. OncoTargets and therapy · 2018
    Article
  17. Role of ICG-European journal of nuclear medicine and molecular imaging · 2017
    Article
  18. Article
  19. Article
  20. The sentinel node approach in gynaecological malignancies.Clinical and translational imaging · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Francesco GiammarileMédecine Nucléaire, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon and EMR HCL/UCBL, Faculté de Médecine, Université Claude Bernard, Lyon 1, Villeurbanne, France, francesco.giammarile@chu-lyon.fr.
M Fani Bozkurt
David Cibula
Jaume Pahisa
Wim J Oyen
Pilar Paredes
Renato Valdes Olmos
Sergi Vidal Sicart
Hospital Clínic de Barcelona · ESCharles University · CZHacettepe University · TRHôpital Lyon Sud · FRLeiden University Medical Center · NLRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accurate harvesting of a sentinel node in gynaecological cancer (i.e. vaginal, vulvar, cervical, endometrial or ovarian cancer) includes a sequence of procedures with components from different medical specialities (nuclear medicine, radiology, surgical oncology and pathology). These guidelines are divided into sectione entitled: Purpose, Background information and definitions, Clinical indications and contraindications for SLN detection, Procedures (in the nuclear medicine department, in the surgical suite, and for radiation dosimetry), and Issues requiring further clarification. The guidelines were prepared for nuclear medicine physicians. The intention is to offer assistance in optimizing the diagnostic information that can currently be obtained from sentinel lymph node procedures. If specific recommendations given cannot be based on evidence from original scientific studies, referral is made to "general consensus" and similar expressions. The recommendations are designed to assist in the practice of referral to, and the performance, interpretation and reporting of all steps of the sentinel node procedure in the hope of setting state-of-the-art standards for high-quality evaluation of possible metastatic spread to the lymphatic system in gynaecological cancer. The final result has been discussed by a group of distinguished experts from the EANM Oncology Committee and the European Society of Gynaecological Oncology (ESGO). The document has been endorsed by the SNMMI Board.

Indexed as

Coloring AgentsFemaleGenital Neoplasms, FemaleHumansImage Processing, Computer-AssistedInjectionsLymphoscintigraphyNuclear MedicineOccupational ExposureQuality ControlRadioactive WasteRadiometryRadiopharmaceuticalsResearch DesignSentinel Lymph Node BiopsyColoring AgentsRadioactive WasteRadiopharmaceuticals

Identifiers

PMID24609929
OpenAlexW2170344346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.